C-Kit is an Oncogene first found in a Feline Retrovirus Besmer, P., J. E. Murphy, P. C. George, F. Qui, P. J. Bergold, L. Lederman, H. W. Snyder Jr., D.

Slides:



Advertisements
Similar presentations
Stem Cells and Cell Signaling
Advertisements

Gastrointestinal Stromal Tumor
C-Kit and Gastrointestinal Stromal Tumors By Jessica Danielle Stewart
PDGF  c-sis of Simian Sarcoma) Dermatofibrosarcoma.
Transforming Growth Factor β Receptor Type II Tina Morris
PDGF β Receptor. Protein 1106 amino acid protein Weinberg Fig 5.10.
Copyright (c) by W. H. Freeman and Company Chapter 24 Cancer.
Transforming Growth Factor-Beta Receptor 2 TGF-β receptor 2
 2014 Genentech USA, Inc. All rights reserved. 1 Disclosure/Disclaimer The Molecular Basis of Cancer Educational Series is not intended to promote any.
 2013 Genentech USA, Inc. All rights reserved. Disclosure/Disclaimer The Molecular Basis of Lung Cancer slide presentation is not an independent educational.
MAHNAZ JANGHORBAN CANB610 3/8/2012 ETV1 and GIST Pathogenesis Gastrointestinal stromal tumors (GISTs) arise from the interstitial cells of Cajal (ICC)
Resistance to TK inhibitors: KIT and PDGFRA Maria Debiec-Rychter, M.D., Ph.D. Center for Human Genetics, KULeuven, Belgium ESMO meeting Milan, May 13th,
Jennie Bell CMGS/ACC Spring meeting 14 th April 2010.
Colony-Stimulating Factor Receptor (CSF-1R); c-fms.
Chapter 20 oncogene, anti-oncogene and growth factor The biochemistry and molecular biology department of CMU.
RET Proto-Oncogene of Multiple Endocrine Neoplasia type 2(MEN2)
RET Proto- Oncogene in The Development of Thyroid Cancer: Multiple Endocrine Neoplasia Type 2 Courtney Brooks.
CHAPTER 5 Growth Factors, Receptors, and Cancer The human EGF receptor (HER) signaling network.
An Extremely Rare Case Report
GISTs- Gastrointestinal Stromal Tumor
Gastrointestinal Stromal Tumours(GIST)
Francisco G. La Rosa MD Pathologist, Assistant Professor Department of Pathology, UCHSC * In collaboration with * In collaboration with S. Russell Nash,
C-kit Katie Wilson.
Tumorigenesis to Cancer Development Pin Ling ( 凌 斌 ), Ph.D. ext 5632; References: 1.Chapter 23 Cancer in “Molecular Cell Biology”
Prof. Janusz Limon, MD, PhD
Here are some CML slides that may be helpful for your presentation.
Cancer Tumor Cells and the Onset of Cancer
BIOL 445 – CANCER BIOLOGY PRESENTATION
FGFR3 and Bladder Cancer Amy Fair March 29, 2005 Biol 169.
Ishita Das
oncogene, anti-oncogene and growth factor
DEMI DABOR-ALLOH TGF-β Receptor II and Gastric Cancer.
Tyrosine Kinases as Targets for Cancer Therapy Krause DS, Van Etten RA N Engl J Med 2005;353(2): Krause DS, Van Etten RA N Engl J Med 2005;353(2):
ETV1 IS A LINEAGE SURVIVAL FACTOR THAT COOPERATES WITH KIT IN GASTROINTESTINAL STROMAL TUMORS Introduction Tim Butler March 8 th, 2012.
Cancer. Cancer is a disease of the cell cycle Caused by one or more of the following: Increase in growth signals Loss of inhibitory signals In addition,
Mastocytosis Proliferation of mast cells accumulation in organs Heterogen. manifestations (spontan. regression x aggresive) Cutaneous Systemic.
Regulation of the Cell Cycle The cell cycle can be regulated at any of the phases, but typically, variability in the length of the cell cycle is based.
Viral transformation and oncogenesis Fahareen –Binta –Mosharraf MNS.
Colon cancer: the second leading cause of cancer deaths in the U.S. Polyps, the first stage In tumor development
Date of download: 9/17/2016 Copyright © 2016 McGraw-Hill Education. All rights reserved. Schematic comparison of structural features of cell surface growth.
C-Kit Piebaldism Gastrointestinal stromal tumors.
Samsung Genome Institute Samsung Medical Center
Gastrointestinal Stromal Tumors
Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non- small cell lung cancer: Focus on epidermal growth factor receptor.
Figure 1. Resistance mechanism against first generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). (A) Mutations in the EGFR.
The Role of Notch1 signaling in T-cell acute lymphoblastic leukemia
Volume 115, Issue 5, Pages (November 1998)
Controls the Cell Cycle
Gastrointestinal Stromal Tumors: Disease and Treatment Update
Figure 1 Key time points in the discovery and development of imatinib for the treatment of chronic myeloid leukaemia (CML) and gastrointestinal stromal.
Rethinking bioactivity of FLT3 inhibitors
Chapter 17: Regulation of cell number
Applying Genomic Profiling to Precision Cancer Medicine in Clinical Practice George D. Demetri MD Senior Vice-President for Experimental Therapeutics.
Volume 125, Issue 3, Pages (September 2003)
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Notch1 and its role in pre-T-cell acute lymphoblastic leukemia (T-ALL)
Extracellular Regulation of Apoptosis
BIOLOGY 12 Cancer.
Maria M. Mihaylova, David M. Sabatini, Ömer H. Yilmaz  Cell Stem Cell 
C-Kit Overexpression in Gastrointestinal Stromal Tumors
Corrupted tensional homeostasis accompanies tumor progression.
Gastrointestinal Stromal Tumors: Disease and Treatment Update
Volume 115, Issue 5, Pages (November 1998)
Oncogenic ALK signaling.
Canonical gliomagenesis mediators EGFR, P53, and retinoblastoma protein (RB1) are important for cancer signaling. Canonical gliomagenesis mediators EGFR,
Molecular Characterization of Acquired Resistance to the BRAF Inhibitor Dabrafenib in a Patient with BRAF-Mutant Non–Small-Cell Lung Cancer  Charles M.
Protein expression profile in a dasatinib-resistant cell line.
Location of common clinically relevant mutations in EGFR
BCR/ABL expression, tyrosine phosphorylation, and signaling in dasatinib- and imatinib-resistant cell lines and the ubiquitin inhibitor lactacystin modifies.
Presentation transcript:

c-Kit is an Oncogene first found in a Feline Retrovirus Besmer, P., J. E. Murphy, P. C. George, F. Qui, P. J. Bergold, L. Lederman, H. W. Snyder Jr., D. Brodeur, E. E. Zukerman, and W. D. Hardy A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature (Lond.). 320:

c-Kit is a Receptor Tyrosine Kinase that is Activated in Human Cancers Yarden, Y. et al. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. The EMBO Journal :

c-Kit Activates Many Signaling Pathways Corless, C.L., Heinrich, M.C. Molecular Pathobiology of Gastrointestinal Stromal Sarcomas. Annu. Rev. Pathol. Mech. Dis :

c-Kit is Essential for Proper Hematopoiesis and Intestinal Function Kimura Y, Ding B, Imai N, Nolan DJ, Butler JM, et al. (2011) c-Kit- Mediated Functional Positioning of Stem Cells to Their Niches Is Essential for Maintenance and Regeneration of Adult Hematopoiesis. PLoS ONE 6(10): e Maeda, H. et al. Requirement of c-kit for development of intestinal pacemaker system. Development 116, (1992)

GIST is a Mesenchymal Tumor that Arises in the Smooth Muscle Wall of GI Tract Corless, C.L., Heinrich, M.C. Molecular Pathobiology of Gastrointestinal Stromal Sarcomas. Annu. Rev. Pathol. Mech. Dis :

c-Kit Mutations in GIST Result in Constitutive Activation Seiichi Hirota et al. Gain-of-Function Mutations of c-kit in Human Gastrointestinal Stromal Tumors. Science, New Series, Vol. 279, No (Jan. 23, 1998), pp

Mutations Activating c-Kit Result in Cell Proliferation and Tumor Growth Seiichi Hirota et al. Gain-of-Function Mutations of c-kit in Human Gastrointestinal Stromal Tumors. Science, New Series, Vol. 279, No (Jan. 23, 1998), pp

c-Kit Mutations Are Found in 80% of GISTs, With the Majority of Mutations Occurring in the Juxtamembrane Domain Corless, C.L., Heinrich, M.C. Molecular Pathobiology of Gastrointestinal Stromal Sarcomas. Annu. Rev. Pathol. Mech. Dis :

GISTs Are Treatable by the Kinase Inhibitor Imatinib/Gleevec Corless, C.L., Heinrich, M.C. Molecular Pathobiology of Gastrointestinal Stromal Sarcomas. Annu. Rev. Pathol. Mech. Dis :

Imatinib Resistance Leads to Use of Secondary Therapies/Cocktail Therapy

References Besmer, P., J. E. Murphy, P. C. George, F. Qui, P. J. Bergold, L. Lederman, H. W. Snyder Jr., D. Brodeur, E. E. Zukerman, and W. D. Hardy A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature (Lond.). 320: Yarden, Y. et al. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. The EMBO Journal : Corless, C.L., Heinrich, M.C. Molecular Pathobiology of Gastrointestinal Stromal Sarcomas. Annu. Rev. Pathol. Mech. Dis : Kimura Y, Ding B, Imai N, Nolan DJ, Butler JM, et al. (2011) c-Kit-Mediated Functional Positioning of Stem Cells to Their Niches Is Essential for Maintenance and Regeneration of Adult Hematopoiesis. PLoS ONE 6(10): e Maeda, H. et al. Requirement of c-kit for development of intestinal pacemaker system. Development 116, (1992) Hirota, S. et al. Gain-of-Function Mutations of c-kit in Human Gastrointestinal Stromal Tumors. Science, New Series, Vol. 279, No (Jan. 23, 1998), pp Taniguchi, M. et al. Effect of c-kit mutations on prognosis of gastrointestinal stromal tumors. Cancer Res 1999;59: Furitsu T, Tsujimura T, Tono T, et al. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 1993;92Primary structure of c-kit: relationship with the CSF-1/PDGF receptor tyrosine kinase family- oncogenic activation of v-kit involves deletion of extracellular domain and C terminus. EMBO Journal :